RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression

• RAP1-deficient female mice develop obesity that is aggravated under a high-fat diet
• RAP1 protects against obesity, insulin resistance, cardiopathies, and liver steatosis
• RAP1 modulates the transcriptional regulation of metabolic pathways
• RAP1 binds to Pparα and Pgc1α loci and modulates their transcription

SummaryRAP1 is part of shelterin, the protective complex at telomeres. RAP1 also binds along chromosome arms, where it is proposed to regulate gene expression. To investigate the nontelomeric roles of RAP1 in vivo, we generated a RAP1 whole-body knockout mouse. These mice show early onset of obesity, which is more severe in females than in males. Rap1-deficient mice show accumulation of abdominal fat, hepatic steatosis, and high-fasting plasma levels of insulin, glucose, cholesterol, and alanine aminotransferase. Gene expression analyses of liver and visceral white fat from Rap1-deficient mice before the onset of obesity show deregulation of metabolic programs, including fatty acid, glucose metabolism, and PPARα signaling. We identify Pparα and Pgc1α as key factors affected by Rap1 deletion in the liver. We show that RAP1 binds to Pparα and Pgc1α loci and modulates their transcription. These findings reveal a role for a telomere-binding protein in the regulation of metabolism.

Graphical AbstractFigure optionsDownload as PowerPoint slide